Point72 Asset Management, L.P. 13D and 13G filings for Mereo BioPharma Group plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 4:03 pm Sale |
2022-12-31 | 13G | Mereo BioPharma Group plc MREO |
Point72 Asset Management, L.P. | 22 0.100% |
-10,609,978 (-100.00%) |
Filing |
| 2022-02-14 4:50 pm Purchase |
2021-12-31 | 13G | Mereo BioPharma Group plc MREO |
Point72 Asset Management, L.P. | 10,610,000 9.100% |
3,710,331 (+53.78%) |
Filing |
| 2021-03-01 5:19 pm Purchase |
2021-02-17 | 13G | Mereo BioPharma Group plc MREO |
Point72 Asset Management, L.P. | 6,899,669 6.400% |
6,899,669 (New Position) |
Filing |